Steven Wolk

Steven Wolk has over 30 years of experience in the pharmaceutical and biotechnology industry. Currently, they serve as the Vice President of Chemistry and Boulder Site Head at Editas Medicine, a position they have held since January 2023. Prior to this role, they were the Vice President of Analytical Chemistry and Site Head at Editas Medicine from August 2021 to February 2023. Before joining Editas Medicine, they worked at SomaLogic for 11 years, starting as the Director of Analytical Sciences in June 2008 and staying in that role until March 2019. Steven also has 4 years of experience at Amgen as a Principal Product Quality Leader from 2004 to 2008. Earlier in their career, they held positions at Invenux, Nexstar, Rohm and Haas, and Rohm and Haas Research Laboratories as a Senior Scientist and Spectroscopy Group Leader.

Steven Wolk obtained their Ph.D in Biophysical Chemistry from the University of California, Berkeley between 1983 and 1988.